.jpg)
Cost Sharing for Preferred Branded Drugs in Medicare Part D
This study uses data from the Centers for Medicare & Medicaid Services Public Use Files to examine the use of co-payments and co-insurance for preferred brand-name drugs among Medicare Part D plans from 2020 to 2024 and characterize beneficiary exposure to these trends.
This study uses data from the Centers for Medicare & Medicaid Services Public Use Files to examine the use of co-payments and co-insurance for preferred brand-name drugs among Medicare Part D plans from 2020 to 2024 and characterize beneficiary exposure to these trends.
